20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bausch + Lomb Corp (BLCO) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Vaughan, Canada with about 13,000 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2025-12-31, BLCO reported $5.1B in revenue and ($360M) in net income.
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical.
Interactive charts & full statements → Open the BLCO valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $5.3B | $5.1B | $4.8B | $4.1B | $3.8B | $3.8B | $3.4B | $3.8B | $3.7B |
| Gross Profit | $3.0B | $2.8B | $2.9B | $2.5B | $2.2B | $2.3B | $2.1B | $2.5B | $2.4B |
| Gross Margin % | 57.2% | 54.8% | 60.9% | 60.4% | 59.7% | 61.0% | 62.3% | 64.9% | 64.2% |
| Operating Income (EBIT) | $380M | $188M | $162M | $130M | $207M | $329M | $260M | $396M | $416M |
| Operating Margin % | 7.1% | 3.7% | 3.4% | 3.1% | 5.5% | 8.7% | 7.6% | 10.5% | 11.3% |
| Net Income | ($171M) | ($360M) | ($317M) | ($260M) | $6M | $182M | ($18M) | $298M | $710M |
| Net Margin % | -3.2% | -7.1% | -6.6% | -6.3% | 0.2% | 4.8% | -0.5% | 7.9% | 19.4% |
| EBITDA | $742M | $535M | $601M | $499M | $598M | $733M | $732M | $936M | $922M |
| Earnings Per Share (EPS) | $-0.48 | $-1.02 | $-0.90 | $-0.74 | $0.02 | $0.52 | $-0.05 | $0.85 | $2.03 |
| Shares Outstanding (M) | 357M | 354M | 352M | 350M | 350M | 350M | 350M | 350M | 350M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.4B | $1.2B | $1.4B | $1.3B | $1.3B | $1.1B | $1.3B | $1.2B |
| Gross Profit | $821M | $704M | $816M | $703M | $686M | $588M | $779M | $732M |
| Gross Margin % | 59.1% | 56.6% | 58.1% | 54.9% | 53.7% | 51.7% | 60.9% | 61.2% |
| Operating Income (EBIT) | $83M | $59M | $158M | $80M | $11M | ($61M) | $87M | $43M |
| Operating Margin % | 6.0% | 4.7% | 11.2% | 6.2% | 0.9% | -5.4% | 6.8% | 3.6% |
| Net Income | ($14M) | ($71M) | ($58M) | ($28M) | ($62M) | ($212M) | ($3M) | $4M |
| Net Margin % | -1.0% | -5.7% | -4.1% | -2.2% | -4.9% | -18.6% | -0.2% | 0.3% |
| EBITDA | $184M | $137M | $212M | $209M | $91M | $23M | $194M | $152M |
| Earnings Per Share (EPS) | $-0.04 | $-0.20 | $-0.16 | $-0.08 | $-0.18 | $-0.60 | $-0.01 | $0.01 |
| Shares Outstanding (M) | 357M | 355M | 354M | 354M | 354M | 353M | 352M | 354M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $458M | $283M | $232M | ($17M) | $345M | $873M | $522M | $799M | $763M |
| Capital Expenditures (CapEx) | $318M | $349M | $291M | $181M | $175M | $193M | $259M | $180M | $101M |
| Free Cash Flow (FCF) | $140M | ($66M) | ($59M) | ($198M) | $170M | $680M | $263M | $619M | $662M |
| FCF Margin % | 2.6% | -1.3% | -1.2% | -4.8% | 4.5% | 18.1% | 7.7% | 16.4% | 18.1% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $153M | $32M | $134M | $139M | $35M | ($25M) | $22M | $154M |
| Capital Expenditures (CapEx) | $71M | $100M | $73M | $75M | $89M | $110M | $92M | $60M |
| Free Cash Flow (FCF) | $82M | ($68M) | $62M | $65M | ($54M) | ($135M) | ($70M) | $94M |
| FCF Margin % | 5.9% | -5.5% | 4.4% | 5.0% | -4.2% | -11.9% | -5.5% | 7.9% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.9B | $14.0B | $13.5B | $13.4B | $11.1B | $10.8B | $11.3B | $11.5B |
| Cash & Cash Equivalents | $367M | $383M | $305M | $334M | $380M | $174M | $238M | $192M |
| Total Liabilities | $7.4B | $7.5B | $6.9B | $6.5B | $4.0B | $1.4B | $1.3B | $1.4B |
| Total Debt (Short + Long-Term) | $5.1B | $5.1B | $4.8B | $4.6B | $2.5B | $48M | $18M | $16M |
| Total Shareholders' Equity | $6.4B | $6.4B | $6.5B | $6.8B | $7.0B | $9.3B | $9.9B | $10.0B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BLCO viewer.
About TickerBase · Data methodology & sources · Privacy · Terms